IMDX Q2 2026 earnings call highlights: GraftAssureDx FDA timing, MolDX reimbursement tailwind, cash burn outlook, runway levers, and launch plans—read now.
$IMDX
Price history, market instrument context, member research, and related headlines in one place.
IMDX key statistics
NasdaqCMUSD
52-week range
$2.426%$8.51
Latest session $2.75–$3.10Insight Molecular Diagnostics Inc. (IMDX) is a stock instrument quoted on NasdaqCM in USD. The most recently published price is $2.79, down $0.20 (6.69%) from the previous close of $2.99. It has traded between $2.75 and $3.10 in the latest session. Over the past year it has ranged from $2.42 to $8.51, leaving it in the lower quarter of its 52-week range (6%). Reported volume for the session was 407.5K. Figures are the latest published by the exchange feed and are not a recommendation.
Primary market bars from Yahoo Finance · Extended-hours prints appear when supplied by the venue · Interactive charts powered by TradingView Lightweight Charts™ · Not a recommendation
Source-linked intelligence
Related news
Insight Molecular Diagnostics Inc. Non-GAAP EPS of -$0.23 in-line, revenue of $0.24M misses by $0.2M — See source for full details.
Insight Molecular Diagnostics Q2 2026 Earnings Preview — See source for full details.
Loading $IMDX research…